We are live on
!
Find out more
BFO
Boston Family Office Portfolio holdings
AUM
$1.5B
1-Year Est. Return
11.68%
This Fund
S&P 500
This Quarter
Est. Return
+2.08%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$770M
AUM Growth
-$1.67M
(-0.22%)
Cap. Flow
-$10.2M
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
20.83%
Holding
246
New
3
Increased
56
Reduced
119
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$2.63M |
| 2 |
Amazon
AMZN
|
+$694K |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$443K |
| 4 |
FISV
Fiserv Inc
FISV
|
+$419K |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$359K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRCL
Stericycle Inc
SRCL
|
+$2.14M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$1.42M |
| 3 |
AptarGroup
ATR
|
+$1.2M |
| 4 |
Gilead Sciences
GILD
|
+$1.12M |
| 5 |
Middleby
MIDD
|
+$1.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.33% |
| 2 | Industrials | 14.26% |
| 3 | Technology | 12.55% |
| 4 | Consumer Staples | 10.47% |
| 5 | Financials | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.97T
| $19.5M | 2.53% |
672,572
-6,316
| -0.9% | -$179K |
|
2
Johnson & Johnson
JNJ
$640B
| $19.3M | 2.51% |
167,930
-1,115
| -0.7% | -$129K |
|
3
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| $18.5M | 2.41% |
82,934
+388
| +0.5% | +$84.8K |
|
4
ExxonMobil
XOM
$650B
| $17.5M | 2.27% |
193,536
-498
| -0.3% | -$43.5K |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $16.6M | 2.16% |
143,840
-3,960
| -3% | -$441K |
|
6
Union Pacific
UNP
$174B
| $15.5M | 2.02% |
149,863
-2,879
| -2% | -$283K |
|
7
Ecolab
ECL
$79.8B
| $13.6M | 1.77% |
115,926
-115
| -0.1% | -$13.5K |
|
|
8
Middleby
MIDD
$6.01B
| $13.4M | 1.74% |
103,837
-8,395
| -7% | -$1.06M |
|
|
ANSS
9
DELISTED
Ansys
ANSS
| $13.2M | 1.72% |
143,151
-6,525
| -4% | -$601K |
|
10
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
| $13.1M | 1.71% |
43,560
-422
| -1% | -$122K |
|
11
American Tower
AMT
$83.5B
| $13M | 1.69% |
122,942
-2,485
| -2% | -$270K |
|
12
Vanguard FTSE Emerging Markets ETF
VWO
$117B
| $12.6M | 1.64% |
353,236
-10,220
| -3% | -$374K |
|
13
General Mills
GIS
$20.2B
| $12.4M | 1.61% |
200,757
-446
| -0.2% | -$27.6K |
|
|
MRSH
14
Marsh
MRSH
$94.3B
| $12.3M | 1.6% |
181,837
-206
| -0.1% | -$13.8K |
|
15
Rockwell Automation
ROK
$51.1B
| $11.8M | 1.54% |
88,084
-440
| -0.5% | -$56.2K |
|
16
iShares Core S&P Small-Cap ETF
IJR
$109B
| $11.7M | 1.52% |
169,778
-2,678
| -2% | -$173K |
|
17
Procter & Gamble
PG
$340B
| $11.6M | 1.51% |
138,430
-210
| -0.2% | -$17.9K |
|
18
GE Aerospace
GE
$364B
| $11.6M | 1.51% |
76,721
+236
| +0.3% | +$34.3K |
|
|
FRC
19
DELISTED
First Republic Bank
FRC
| $11.4M | 1.48% |
123,270
-1,822
| -1% | -$149K |
|
20
Berkshire Hathaway Class B
BRK.B
$1.1T
| $11.1M | 1.44% |
68,158
-616
| -0.9% | -$94.8K |
|
21
SLB Ltd
SLB
$72.7B
| $11.1M | 1.44% |
131,847
-685
| -0.5% | -$56.1K |
|
|
22
Gilead Sciences
GILD
$165B
| $10.8M | 1.41% |
151,398
-15,110
| -9% | -$1.12M |
|
23
Oracle
ORCL
$339B
| $9.39M | 1.22% |
244,289
-425
| -0.2% | -$16.6K |
|
|
SRCL
24
DELISTED
Stericycle Inc
SRCL
| $8.83M | 1.15% |
114,661
-28,341
| -20% | -$2.14M |
|
25
Nike
NKE
$64.1B
| $8.45M | 1.1% |
166,154
-2,375
| -1% | -$122K |
|
Similar funds
CP
JFGLC
AAM
TP
SCM
FMI
NSGL
RCW
Boston Family Office's Q4 2016 Portfolio in Review
As of Q4 2016, Boston Family Office held 246 positions worth $770M, down 0.22% from $772M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Trading was light in Q4 2016: portfolio turnover was 3.3%. Boston Family Office opened 3 new positions and exited 5, leaving the 246-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.
- Boston Family Office's largest Q4 2016 buy was Juniper Networks: 11,000 shares worth $311K.
- Boston Family Office added most to CVS Health in Q4 2016, an estimated $2.63M increase.
- Boston Family Office's biggest Q4 2016 reduction was Stericycle Inc, cutting an estimated $2.14M.
- Boston Family Office fully exited CF Industries in Q4 2016, selling an estimated $323K.
- Boston Family Office's ten largest holdings make up 21% of its $770M portfolio in Q4 2016.
- Boston Family Office opened 3 new positions and closed 5 in Q4 2016.
- Boston Family Office's portfolio value fell 0.22% quarter-over-quarter to $770M.
Based on Boston Family Office's 13F filing for Q4 2016, filed 6 Feb 2017.